The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2015

Filed:

Jun. 06, 2013
Applicants:

Rey-yuh Wu, New Taipei, TW;

Hui-ling Chen, New Taipei, TW;

Yu-yuan Wu, New Taipei, TW;

Jiann-jyh Huang, New Taipei, TW;

Shoei-sheng Lee, Taichung, TW;

K-lim King, New Taipei, TW;

Inventors:

Rey-Yuh Wu, New Taipei, TW;

Hui-Ling Chen, New Taipei, TW;

Yu-Yuan Wu, New Taipei, TW;

Jiann-Jyh Huang, New Taipei, TW;

Shoei-Sheng Lee, Taichung, TW;

K-Lim King, New Taipei, TW;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/26 (2006.01); A61K 31/397 (2006.01); A61K 31/335 (2006.01); C07C 321/00 (2006.01); C07C 45/00 (2006.01); C07C 47/225 (2006.01); C07D 309/30 (2006.01); C07D 321/04 (2006.01); C07C 47/267 (2006.01); C07D 205/12 (2006.01); C07D 305/14 (2006.01); A61K 31/11 (2006.01); A61K 31/351 (2006.01); A61K 31/357 (2006.01); C07C 47/46 (2006.01); A61K 36/9068 (2006.01); A61K 45/06 (2006.01); A61K 31/365 (2006.01); C07C 47/277 (2006.01); A61K 31/337 (2006.01);
U.S. Cl.
CPC ...
C07C 47/225 (2013.01); A61K 31/11 (2013.01); A61K 31/351 (2013.01); A61K 31/357 (2013.01); A61K 31/365 (2013.01); A61K 31/397 (2013.01); A61K 36/9068 (2013.01); A61K 38/26 (2013.01); A61K 45/06 (2013.01); C07C 47/267 (2013.01); C07C 47/277 (2013.01); C07C 47/46 (2013.01); C07D 205/12 (2013.01); C07D 305/14 (2013.01); C07D 309/30 (2013.01); C07D 321/04 (2013.01); A61K 31/337 (2013.01); C07C 2102/26 (2013.01); C07C 2103/30 (2013.01);
Abstract

A compound for controlling blood glucose level has a structure shown in Formula I: wherein R5-R8 are as defined herein. A method for controlling blood glucose level includes administering to a subject in need thereof a compound of Formula I. The method further includes administering to the subject a GLP-1 receptor ligand. The compound and the GLP-1 receptor ligand may be administered together. The compound may be Galanal A or Galanal B. The GLP-1 receptor ligand may be GLP-1 or exendin-4.


Find Patent Forward Citations

Loading…